Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
if (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) {
'status' => (int) 200,
'contentType' => 'text/html',
'headers' => [
'Content-Type' => [
[maximum depth reached]
]
],
'file' => null,
'fileRange' => [],
'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
'cacheDirectives' => [],
'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-trace').style.display = (document.getElementById('cakeErr67ef80cc6482b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ef80cc6482b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-code').style.display = (document.getElementById('cakeErr67ef80cc6482b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-context').style.display = (document.getElementById('cakeErr67ef80cc6482b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ef80cc6482b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">>
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/>
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/>
</span></span></code></pre><pre id="cakeErr67ef80cc6482b-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br />
<br />
&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br />
<br />
&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 30774,
'metaTitle' => 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine',
'metaKeywords' => 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders',
'metaDesc' => '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...',
'disp' => '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br /><br />&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br /><br />&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.</div>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br />
<br />
&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br />
<br />
&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 30774
$metaTitle = 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine'
$metaKeywords = 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders'
$metaDesc = '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...'
$disp = '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br /><br />&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br /><br />&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
media="all"/>
<title>LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine | Im4change.org</title>
<meta name="description" content="
-AP
New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans..."/>
<script src="https://im4change.in/js/jquery-1.10.2.js"></script>
<script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
<script language="javascript" type="text/javascript">
$(document).ready(function () {
var img = $("img")[0]; // Get my img elem
var pic_real_width, pic_real_height;
$("<img/>") // Make in memory copy of image to avoid css issues
.attr("src", $(img).attr("src"))
.load(function () {
pic_real_width = this.width; // Note: $(this).width() will not
pic_real_height = this.height; // work for in memory images.
});
});
</script>
<style type="text/css">
@media screen {
div.divFooter {
display: block;
}
}
@media print {
.printbutton {
display: none !important;
}
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
<tr>
<td class="top_bg">
<div class="divFooter">
<img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
</div>
</td>
</tr>
<tr>
<td id="topspace"> </td>
</tr>
<tr id="topspace">
<td> </td>
</tr>
<tr>
<td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
<tr>
<td width="100%">
<h1 class="news_headlines" style="font-style:normal">
<strong>MSF challenges Pfizer’s India patent for pneumonia vaccine</strong></h1>
</td>
</tr>
<tr>
<td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.<br /><br />“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”<br /><br />“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.</div> </font>
</td>
</tr>
<tr>
<td> </td>
</tr>
<tr>
<td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
</table></body>
</html>'
}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
$response = object(Cake\Http\Response) {
'status' => (int) 200,
'contentType' => 'text/html',
'headers' => [
'Content-Type' => [
[maximum depth reached]
]
],
'file' => null,
'fileRange' => [],
'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
'cacheDirectives' => [],
'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-trace').style.display = (document.getElementById('cakeErr67ef80cc6482b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ef80cc6482b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-code').style.display = (document.getElementById('cakeErr67ef80cc6482b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-context').style.display = (document.getElementById('cakeErr67ef80cc6482b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ef80cc6482b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">>
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/>
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/>
</span></span></code></pre><pre id="cakeErr67ef80cc6482b-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br />
<br />
&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br />
<br />
&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 30774,
'metaTitle' => 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine',
'metaKeywords' => 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders',
'metaDesc' => '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...',
'disp' => '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br /><br />&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br /><br />&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.</div>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br />
<br />
&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br />
<br />
&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 30774
$metaTitle = 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine'
$metaKeywords = 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders'
$metaDesc = '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...'
$disp = '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br /><br />&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br /><br />&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
media="all"/>
<title>LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine | Im4change.org</title>
<meta name="description" content="
-AP
New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans..."/>
<script src="https://im4change.in/js/jquery-1.10.2.js"></script>
<script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
<script language="javascript" type="text/javascript">
$(document).ready(function () {
var img = $("img")[0]; // Get my img elem
var pic_real_width, pic_real_height;
$("<img/>") // Make in memory copy of image to avoid css issues
.attr("src", $(img).attr("src"))
.load(function () {
pic_real_width = this.width; // Note: $(this).width() will not
pic_real_height = this.height; // work for in memory images.
});
});
</script>
<style type="text/css">
@media screen {
div.divFooter {
display: block;
}
}
@media print {
.printbutton {
display: none !important;
}
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
<tr>
<td class="top_bg">
<div class="divFooter">
<img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
</div>
</td>
</tr>
<tr>
<td id="topspace"> </td>
</tr>
<tr id="topspace">
<td> </td>
</tr>
<tr>
<td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
<tr>
<td width="100%">
<h1 class="news_headlines" style="font-style:normal">
<strong>MSF challenges Pfizer’s India patent for pneumonia vaccine</strong></h1>
</td>
</tr>
<tr>
<td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.<br /><br />“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”<br /><br />“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.</div> </font>
</td>
</tr>
<tr>
<td> </td>
</tr>
<tr>
<td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
</table></body>
</html>'
}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
$response = object(Cake\Http\Response) {
'status' => (int) 200,
'contentType' => 'text/html',
'headers' => [
'Content-Type' => [
[maximum depth reached]
]
],
'file' => null,
'fileRange' => [],
'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
'cacheDirectives' => [],
'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-trace').style.display = (document.getElementById('cakeErr67ef80cc6482b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ef80cc6482b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-code').style.display = (document.getElementById('cakeErr67ef80cc6482b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ef80cc6482b-context').style.display = (document.getElementById('cakeErr67ef80cc6482b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ef80cc6482b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">>
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/>
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/>
</span></span></code></pre><pre id="cakeErr67ef80cc6482b-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br />
<br />
&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br />
<br />
&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 30774,
'metaTitle' => 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine',
'metaKeywords' => 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders',
'metaDesc' => '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...',
'disp' => '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br /><br />&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br /><br />&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.</div>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br />
<br />
&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br />
<br />
&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 30774
$metaTitle = 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine'
$metaKeywords = 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders'
$metaDesc = '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...'
$disp = '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer&rsquo;s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer&rsquo;s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />&ldquo;The pneumonia vaccine is the world&rsquo;s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,&rdquo; Dr Manica Balasegaram, executive director of MSF&rsquo;s Access Campaign, said in the statement.<br /><br />&ldquo;Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can&rsquo;t afford it.&rdquo;<br /><br />&ldquo;To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,&rdquo; Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer&rsquo;s patent application comes after &ldquo;years of fruitless negotiations&rdquo; to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />&ldquo;As doctors who have watched far too many children die of pneumonia, we&rsquo;re not going to back down until we know that all countries can afford this vaccine,&rdquo; Balasegaram said.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
media="all"/>
<title>LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine | Im4change.org</title>
<meta name="description" content="
-AP
New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans..."/>
<script src="https://im4change.in/js/jquery-1.10.2.js"></script>
<script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
<script language="javascript" type="text/javascript">
$(document).ready(function () {
var img = $("img")[0]; // Get my img elem
var pic_real_width, pic_real_height;
$("<img/>") // Make in memory copy of image to avoid css issues
.attr("src", $(img).attr("src"))
.load(function () {
pic_real_width = this.width; // Note: $(this).width() will not
pic_real_height = this.height; // work for in memory images.
});
});
</script>
<style type="text/css">
@media screen {
div.divFooter {
display: block;
}
}
@media print {
.printbutton {
display: none !important;
}
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
<tr>
<td class="top_bg">
<div class="divFooter">
<img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
</div>
</td>
</tr>
<tr>
<td id="topspace"> </td>
</tr>
<tr id="topspace">
<td> </td>
</tr>
<tr>
<td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
<tr>
<td width="100%">
<h1 class="news_headlines" style="font-style:normal">
<strong>MSF challenges Pfizer’s India patent for pneumonia vaccine</strong></h1>
</td>
</tr>
<tr>
<td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.<br /><br />“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”<br /><br />“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.</div> </font>
</td>
</tr>
<tr>
<td> </td>
</tr>
<tr>
<td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
<form><input type="button" value=" Print this page "
onclick="window.print();return false;"/></form>
</td>
</tr>
</table></body>
</html>'
}
$cookies = []
$values = [
(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39
Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
'article_current' => object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.<br />
<br />
“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”<br />
<br />
“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
[maximum depth reached]
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
[maximum depth reached]
],
'[dirty]' => [[maximum depth reached]],
'[original]' => [[maximum depth reached]],
'[virtual]' => [[maximum depth reached]],
'[hasErrors]' => false,
'[errors]' => [[maximum depth reached]],
'[invalid]' => [[maximum depth reached]],
'[repository]' => 'Articles'
},
'articleid' => (int) 30774,
'metaTitle' => 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine',
'metaKeywords' => 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders',
'metaDesc' => '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...',
'disp' => '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.<br /><br />“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”<br /><br />“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.</div>',
'lang' => 'English',
'SITE_URL' => 'https://im4change.in/',
'site_title' => 'im4change',
'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {
'id' => (int) 30774,
'title' => 'MSF challenges Pfizer’s India patent for pneumonia vaccine',
'subheading' => '',
'description' => '<div align="justify">
-AP<br />
<br />
<em>New Delhi: </em>Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br />
<br />
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br />
<br />
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br />
<br />
“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.<br />
<br />
“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”<br />
<br />
“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.<br />
<br />
Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.<br />
<br />
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br />
<br />
Pneumonia kills almost a million children each year.<br />
<br />
“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.
</div>',
'credit_writer' => 'Hindustan Times, 12 March, 2016, http://www.hindustantimes.com/business/msf-challenges-pfizer-s-india-patent-for-pneumonia-vaccine/story-LlXQhDGPusw6AempvnxDhP.html',
'article_img' => '',
'article_img_thumb' => '',
'status' => (int) 1,
'show_on_home' => (int) 1,
'lang' => 'EN',
'category_id' => (int) 16,
'tag_keyword' => '',
'seo_url' => 'msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839',
'meta_title' => null,
'meta_keywords' => null,
'meta_description' => null,
'noindex' => (int) 0,
'publish_date' => object(Cake\I18n\FrozenDate) {},
'most_visit_section_id' => null,
'article_big_img' => null,
'liveid' => (int) 4678839,
'created' => object(Cake\I18n\FrozenTime) {},
'modified' => object(Cake\I18n\FrozenTime) {},
'edate' => '',
'tags' => [
(int) 0 => object(Cake\ORM\Entity) {},
(int) 1 => object(Cake\ORM\Entity) {},
(int) 2 => object(Cake\ORM\Entity) {},
(int) 3 => object(Cake\ORM\Entity) {},
(int) 4 => object(Cake\ORM\Entity) {},
(int) 5 => object(Cake\ORM\Entity) {},
(int) 6 => object(Cake\ORM\Entity) {}
],
'category' => object(App\Model\Entity\Category) {},
'[new]' => false,
'[accessible]' => [
'*' => true,
'id' => false
],
'[dirty]' => [],
'[original]' => [],
'[virtual]' => [],
'[hasErrors]' => false,
'[errors]' => [],
'[invalid]' => [],
'[repository]' => 'Articles'
}
$articleid = (int) 30774
$metaTitle = 'LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine'
$metaKeywords = 'Medicine Prices,Access to Healthcare,Access to Medicines,Pneumonia,Public Health,patents,Doctors Without Borders'
$metaDesc = '
-AP
New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans...'
$disp = '<div align="justify">-AP<br /><br /><em>New Delhi: </em>Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.<br /><br />The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.<br /><br />If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.<br /><br />“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.<br /><br />“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”<br /><br />“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.<br /><br />Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.<br /><br />Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.<br /><br />Pneumonia kills almost a million children each year.<br /><br />“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
latest-news-updates/msf-challenges-pfizers-india-patent-for-pneumonia-vaccine-4678839.html"/>
LATEST NEWS UPDATES | MSF challenges Pfizer’s India patent for pneumonia vaccine | Im4change.org
MSF challenges Pfizer’s India patent for pneumonia vaccine
-AP
New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations.
The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.
If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.
“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product,” Dr Manica Balasegaram, executive director of MSF’s Access Campaign, said in the statement.
“Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can’t afford it.”
“To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges,” Balasegaram said.
Doctors Without Borders said its decision to oppose New-York based Pfizer’s patent application comes after “years of fruitless negotiations” to get the company to reduce the price of the drug for use in humanitarian projects.
Pfizer India said on Saturday that the company had not yet received a copy of the patent opposition and that it was in talks with health officials to try to assess local needs.
Pneumonia kills almost a million children each year.
“As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine,” Balasegaram said.
